Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- SCS +6.6%, AZO +2.6%
M&A news:
- BOBE +5.7% (Post Holdings (POST) to acquire Bob Evans Farms for $77.00/share)
- RAD +2.2% (confirms regulatory clearance for an amended and restated asset purchase agreement with Walgreens Boots Alliance (WBA))
- JONE +1.4% ( Fir Tree Partners calls on Jones Energy to pursue value-maximizing strategic alternatives)
Other news:
- STAF +62.1% (refinances balance sheet, announces closing of two acquisitions)
- PRQR +5.9% (announces that investigational drug QR-313 for dystrophic epidermolysis bullosa has received orphan drug designation from the FDA)
- REXX +5.5% (provides an update for its Moraine East Area operations, remains on target to meet its Q3 production guidance of 171.0 -- 181.0 MMcfe/d and its FY 17 exit rate production growth rate guidance of 15% - 20%)
- DRNA +5% (Bain Capital Life Sciences Fund discloses increased active stake),
- NBRV +5% (continued strength; also commences an underwritten public offering of $80.0 mln of ordinary shares)
- UBNT +3.2% (adds $100 mln to repurchase program, updates Q1 guidance, reaffirms FY18 outlook)
- NOMD +3.1% (Elliott Associates discloses 5.7% passive stake)
- KTOS +2.1% (Kratos Defense and Security deploys the World's First autonomous vehicle approved and supporting live roadway operation in Colorado )
- SINA +1.7% ( Aristeia Capital confirms has nominated two independent candidates for election to Sina's Board to immediately evaluate and help execute opportunities)
- FOLD +1.7% (FDA has granted Fast Track designation for the oral precision medicine migalastat)
- M +1.4% (Macy's details plans to hire approximately 80,000 seasonal associates)
Analyst comments:
- MRTX +4.6% (initiated with a Outperform at Oppenheimer)
- QDEL +3.9% (upgraded to Overweight from Neutral at Piper Jaffray)
- KORS +3% (upgraded to Outperform from Perform at Oppenheimer)
- GPS +2.2% (upgraded to Neutral from Underperform at Credit Suisse)
- ACIA +1.9% (initiated with a Buy at MKM Partners)
- MLCO +1% (upgraded to Buy from Neutral at Nomura)
- NTAP +0.9% (upgraded to Buy from Neutral at UBS)
- AAPL +0.5% (target raised to $194 from $182 at Morgan Stanley)